Xenetic Biosciences XBIO Q4 2025 Annual earnings
Reported March 12, 2026 · After market close
Revenue$766.3KBeat by $76.3K
EPS-$0.22Beat by $0.30
Revenue estimate$690.0K
EPS estimate-$0.52
Next report
Aug 7, 2026 (In 1 week)Versus estimates
Revenue
Q1 2026$806.9K
Q4 2025$766.3KBeat by $76.3K
Q3 2025$1.0MBeat by $397.0KQ2 2025$589.9KBeat by $110.9KQ1 2025$593.3KBeat by $77.3KQ4 2024$648.8KDiluted EPS
Q1 2026-$0.20
Q4 2025-$0.22Beat by $0.30
Q3 2025-$0.33Beat by $0.16Q2 2025-$0.45Beat by $0.19Q1 2025-$0.59Beat by $0.13Q4 2024-$0.68Ask the moment Xenetic Biosciences reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Xenetic Biosciences report Q4 2025 earnings?
- Xenetic Biosciences (XBIO) reported Q4 2025 earnings on March 12, 2026 after market close.
- What were Xenetic Biosciences's Q4 2025 revenue and EPS?
- Xenetic Biosciences reported revenue of $766.3K and eps of $-0.22 for Q4 2025.
- Did Xenetic Biosciences beat estimates in Q4 2025?
- Revenue beat the consensus estimate of $690.0K by $76.3K. EPS beat the consensus estimate of $-0.52 by $0.30.
- How did Xenetic Biosciences's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 18.1% from $648.8K a year earlier and eps grew 67.8% from $-0.68.
- Where can I find Xenetic Biosciences's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001683168-26-001744) and the 10-K periodic report (0001683168-26-001737) directly on SEC EDGAR. The filing index links above go to sec.gov.